Scholarly Index
Joseph Sodroski
Dana-Farber Cancer Institute; 72,578 total citations; 494 total publications; best world rank #5
Dana-Farber Cancer Institute
72,578Total citations
494Total publications
132H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Biological Sciences | Lifetime | 750 | US 414 | 99.91 |
| Virology | Lifetime | 9 | US 8 | 99.89 |
| Immunology | Lifetime | 184 | US 101 | 99.59 |
| Infectious Diseases | Lifetime | 478 | US 248 | 98.16 |
| Virology | 2021-2025 | 104 | US 58 | 82.06 |
| HIV/AIDS drug development and treatment | Lifetime | 5 | US 4 | 99.93 |
| HIV Research and Treatment | Lifetime | 9 | US 8 | 99.94 |
| T-cell and Retrovirus Studies | Lifetime | 9 | US 7 | 99.66 |
| Immune Cell Function and Interaction | Lifetime | 111 | US 73 | 99.84 |
| Monoclonal and Polyclonal Antibodies Research | Lifetime | 121 | US 83 | 99.70 |
| Animal Disease Management and Epidemiology | Lifetime | 63 | US 26 | 99.48 |
| Vector-Borne Animal Diseases | Lifetime | 54 | US 19 | 99.39 |
| interferon and immune responses | Lifetime | 102 | US 54 | 99.19 |
| Glycosylation and Glycoproteins Research | Lifetime | 462 | US 216 | 98.51 |
| Herpesvirus Infections and Treatments | Lifetime | 310 | US 196 | 98.25 |
| Chemokine receptors and signaling | Lifetime | 393 | US 159 | 94.75 |
| HIV Research and Treatment | 2021-2025 | 677 | US 313 | 89.15 |
| HIV/AIDS drug development and treatment | 2021-2025 | 676 | US 219 | 85.47 |